Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
buy
Transgene S.A.

Start price
Target price
Perf. (%)
€2.43
07.11.21
€2.80
07.11.22
-20.58%
08.11.22

Could be worthwhile Investment >10% per year
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€85.00
05.11.21
€100.00
31.12.23
-63.76%
08.05.23

Could be very worthwhile Investment >20% year
buy
Codexis Inc.

Start price
Target price
Perf. (%)
€34.80
05.11.21
€50.00
31.12.23
-79.99%
07.09.22

Could be very worthwhile Investment >20% year
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€23.30
04.11.21
€10.00
04.11.23
-42.83%
16.12.21

Could be very worthwhile Investment >20% year
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.59
31.10.21
€30.00
31.10.22
8.63%
13.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Krystal Biotech

Start price
Target price
Perf. (%)
€42.60
30.10.21
€37.00
30.11.22
54.93%
01.12.21

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
buy
Otonomy Inc.

Start price
Target price
Perf. (%)
€1.67
25.10.21
€3.00
31.12.23
21.68%
28.06.22

Could be very worthwhile Investment >20% year
buy
Virbac S.A.

Start price
Target price
Perf. (%)
€395.50
25.10.21
€480.00
25.10.22
1.52%
07.11.21

Could be worthwhile Investment >10% per year
Novavax Inc.

Start price
Target price
Perf. (%)
€117.42
20.10.21
€105.00
20.10.22
24.32%
11.11.21

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€2.83
20.10.21
€5.00
31.12.23
-62.30%
08.05.23

Could be very worthwhile Investment >20% year
buy
Applied Genetic Technologies Corp.

Start price
Target price
Perf. (%)
€2.28
20.10.21
€5.00
31.12.23
-84.94%
08.05.23

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Omeros Corp.

Start price
Target price
Perf. (%)
€5.21
19.10.21
-
19.10.22
19.09%
05.11.21

Could be worthwhile Investment >10% per year
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.32
18.10.21
-
18.10.22
6.90%
30.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€5.30
18.10.21
-
18.10.22
-15.62%
30.10.21

Risky Investment
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€14.60
17.10.21
€20.00
31.12.23
-54.93%
08.05.23

Could be very worthwhile Investment >20% year
4d Pharma plc

Start price
Target price
Perf. (%)
€0.80
17.10.21
€0.60
17.10.22
-15.63%
26.11.21

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.80
17.10.21
€25.00
17.10.22
-15.53%
26.11.21

Could be worthwhile Investment >10% per year
Concert Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.44
17.10.21
-
17.10.22
121.23%
28.05.22

Could be worthwhile Investment >10% per year
Durect Corp.

Start price
Target price
Perf. (%)
€1.03
17.10.21
-
17.10.22
-48.06%
18.10.22

Probably not worthwhile Investment